Vitamin D and T-Regulatory Cells in Coronary Artery Disease
NCT ID: NCT01183962
Last Updated: 2011-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
50 participants
INTERVENTIONAL
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Supplementation in CAD and Postchallenge Hyperglycemia
NCT01183442
The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors
NCT02750293
Vitamin D Replacement: The Effect on Statin-Related Myalgias
NCT01022398
Role of Vitamin D in Secondary Prevention of Cardiovascular Events
NCT01018849
Vitamin D, Insulin Resistance, and Cardiovascular Disease
NCT00736632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D
Subject receives daily dose of Vitamin D
Vitamin D
Vitamin D 3000 IU daily
No medicine
Subject does not receive medication
No medication
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D
Vitamin D 3000 IU daily
No medication
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* have a history of medically treated coronary artery disease
Exclusion Criteria
* history of diabetes mellitus
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Creighton University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Creighton University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael DelCore, MD
Role: PRINCIPAL_INVESTIGATOR
Creighton University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Cardiac Center at Creighton University
Omaha, Nebraska, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-15602
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.